📰 Codexis Daily News
Page 5 - Codexis Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Codexis Daily. Real-time updates on events, politics, business and more.
May 12, 2023
HC Wainwright lowered shares of Codexis (NASDAQ:CDXS – Get Rating) from a buy rating to a neutral rating in a report issued on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Codexis’ FY2023 earnings at ($1.10) EPS, Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.27) EPS, Q3 2024 earnings at […]
May 11, 2023
Codexis, Inc. (NASDAQ:CDXS – Get Rating) – Research analysts at HC Wainwright dropped their FY2023 earnings per share (EPS) estimates for Codexis in a research report issued on Tuesday, May 9th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings per share of ($1.10) for the year, down from their […]
May 6, 2023
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings data on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative return on equity of 31.32% and a negative net margin of 41.17%. The business had revenue of $12.98 […]
May 5, 2023
Codexis (NASDAQ:CDXS – Get Rating) announced its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.05), Briefing.com reports. Codexis had a negative net margin of 24.24% and a negative return on equity of 21.78%. The firm had revenue of […]
May 5, 2023
Codexis (NASDAQ:CDXS – Get Rating) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.05), Briefing.com reports. The firm had revenue of $12.98 million during the quarter, compared to analyst estimates of $14.09 million. Codexis had a negative return […]
May 2, 2023
Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant drop in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a drop of 11.0% from the March 31st total of 4,890,000 shares. Currently, 6.9% of the shares of the stock are short sold. Based on an […]
May 1, 2023
Codexis, Inc. (NASDAQ:CDXS – Get Rating) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 4,350,000 shares, a decrease of 11.0% from the March 31st total of 4,890,000 shares. Approximately 6.9% of the company’s stock are short sold. Based on an average trading […]
April 1, 2023
ARK Investment Management LLC lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 7.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,941,985 shares of the biotechnology company’s stock after selling 331,500 shares during the period. ARK […]
February 24, 2023
Codexis (NASDAQ:CDXS – Get Rating) and CN Energy Group. (NASDAQ:CNEY – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership. Earnings & Valuation This table compares Codexis and CN […]